Skip to content

Dr. Jolien Matthys

Active
Private limited companyfounded 2023active for 2 yearsReningesteenweg 7, 8647 Lo-Reninge, BelgiumKBO/BCE: BE 1003.997.213
Summary

Dr. Jolien Matthys has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €157,961 and a net result of €88,810. The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

Source: KBO
Status
Active since 28-12-2023 Normal situation
Activity
“De uitoefening van de algemene geneeskunde in naam van de vennootschap door haar aandeelhouders…” (deed in Dutch)From the articles, 6 activitiesNo NACE code in the KBO yet
Establishment unit
2.353.612.552 3600 Genk, since 28-12-2023
Financial year end
31 December
Peppol
Reachable since 14-05-2025

Board and ownership

Board

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
€112,448
▲ 29.1%
Turnover
≈ €280,000
estimated
Profit
€88,810
▲ 34.3%
Equity
€157,961
▲ 128%
Total assets
€185,111
▲ 107%
Score breakdownraises riskFounded in 2023lowers riskLiquidity: current ratio 6.85, cash €83,181Size: total assets €185,111Equity €157,961 (85.3% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 88% of micro companies without a NACE code
Financial strength · tick: 2024
Strong
Solvency 100=
equity 85.3% of total assets
Liquidity 97+5
short-term debt 14.6% · cash 44.9%
Profitability 100=
return on assets 48.0%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 01-2025: 2.4% 02-2025: 2.4%● unchanged vs 01-2025 03-2025: 2.5%▲ +0.1 percentage points vs 02-2025 04-2025: 2.9%▲ +0.4 percentage points vs 03-2025 05-2025: 3.1%▲ +0.2 percentage points vs 04-2025 06-2025: 3.4%▲ +0.3 percentage points vs 05-2025highest value 07-2025: 0.3%▼ -3.1 percentage points vs 06-2025 08-2025: 0.3%● unchanged vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.4%▲ +0.1 percentage points vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.4%● unchanged vs 03-2026 05-2026: 0.5%▲ +0.1 percentage points vs 04-2026 06-2026: 0.5%● unchanged vs 05-2026 07-2026: 0.5%● unchanged vs 06-2026 08-2026: 0.2%▼ -0.3 percentage points vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026lowest value 10-2026: 0.2%● unchanged vs 09-2026lowest value 11-2026: 0.2%● unchanged vs 10-2026lowest value
Credit of up to €15,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 6.85 (4.41 in 2024), above the usual 1.5. Short-term debt is 14.6% and cash 44.9% of total assets. 14.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 88% on liquidity, 90% on profitability and 94% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 6.85, cash €83,181
NBB · annual accounts
lowers risk · Size: total assets €185,111
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Founded in 2023
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €157,961 (85.3% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
15 days early
2024
57 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 2 accounts on average 36 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Key points

  • Positive: Equity rose in 2025from €69,151 to €157,961 ▲ 128% View

Recent changes

  1. · Gazette deed IncorporationStarting capital €3,000 · Appointment: Jolien Matthys (director)
All 4 events

Key facts about Dr. Jolien Matthys

What is the company number of Dr. Jolien Matthys?
The company number of Dr. Jolien Matthys is 1003.997.213. The VAT number is the same number with BE in front: BE 1003.997.213.
Where is Dr. Jolien Matthys based?
The registered office is at Reningesteenweg 7, 8647 Lo-Reninge.Company details
What is the legal form of Dr. Jolien Matthys?
The legal form of Dr. Jolien Matthys is Private limited company (BV).
When was Dr. Jolien Matthys founded?
Dr. Jolien Matthys was founded on 28-12-2023.
Is Dr. Jolien Matthys still active?
Yes, Dr. Jolien Matthys is an active enterprise in the KBO register.
What is the turnover of Dr. Jolien Matthys?
The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €112,448 and 2,211 comparable companies of the same size. It probably lies between €190,000 and €440,000. It is a rough estimate.Financials
Is Dr. Jolien Matthys profitable?
In financial year 2025, Dr. Jolien Matthys made a profit of €88,810.
Where can I find the annual accounts of Dr. Jolien Matthys?
Dr. Jolien Matthys filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Jolien Matthys due?
Dr. Jolien Matthys must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.